GALIMBERTI, CHIARA
GALIMBERTI, CHIARA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Preliminary characterization of CR13626, a novel tyrosine kinase inhibitor for the treatment of glioblastoma.
2022 Galimberti, C
CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma
2021 Galimberti, C; Piepoli, T; Letari, O; Artusi, R; Persiani, S; Caselli, G; Rovati, L
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation
2015 Caprioli, G; Mammoli, V; Ricciutelli, M; Sagratini, G; Ubaldi, M; Domi, E; Mennuni, L; Sabatini, C; Galimberti, C; Ferrari, F; Milia, C; Comi, E; Lanza, M; Giannella, M; Pigini, M; Del Bello, F
Dendrimeric tetravalent ligands for the serotonin-gated ion channel
2014 Paolino, M; Mennuni, L; Giuliani, G; Anzini, M; Lanza, M; Caselli, G; Galimberti, C; Menziani, M; Donati, A; Cappelli, A
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis
2013 Chiusaroli, R; Visentini, M; Galimberti, C; Casseler, C; Mennuni, L; Covaceuszach, S; Lanza, M; Ugolini, G; Caselli, G; Rovati, L; Visintin, M
| Titolo | Tipologia | Data di pubblicazione | Autori | File |
|---|---|---|---|---|
| Preliminary characterization of CR13626, a novel tyrosine kinase inhibitor for the treatment of glioblastoma. | 07 - Tesi di dottorato Bicocca post 2009 | 2022 | GALIMBERTI, CHIARA | |
| CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma | 01 - Articolo su rivista | 2021 | Galimberti, Chiara + | |
| Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation | 01 - Articolo su rivista | 2015 | SABATINI, CHIARAGalimberti, CMILIA, CHIARACOMI, ELEONORA + | |
| Dendrimeric tetravalent ligands for the serotonin-gated ion channel | 01 - Articolo su rivista | 2014 | Galimberti C. + | |
| Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis | 01 - Articolo su rivista | 2013 | Galimberti C. + |